vs

Side-by-side financial comparison of CITY HOLDING CO (CHCO) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Tarsus Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($151.7M vs $80.2M, roughly 1.9× CITY HOLDING CO). CITY HOLDING CO runs the higher net margin — 39.4% vs -5.5%, a 44.9% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 11.8%). CITY HOLDING CO produced more free cash flow last quarter ($128.4M vs $13.0M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 5.3%).

Jam City, Inc. is an American video game developer and publisher based in Culver City, California. The company was founded in 2010 by Chris DeWolfe, Colin Digiaro, Aber Whitcomb, and Josh Yguado. Jam City has nine studios located in the United States, Canada, South America, and Europe. As of 2021, it employs 825 people. Netmarble is the largest shareholder in Jam City. As of 2021, Jam City's games have 31 million monthly active users and 1.3 billion total downloads.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

CHCO vs TARS — Head-to-Head

Bigger by revenue
TARS
TARS
1.9× larger
TARS
$151.7M
$80.2M
CHCO
Growing faster (revenue YoY)
TARS
TARS
+116.6% gap
TARS
128.4%
11.8%
CHCO
Higher net margin
CHCO
CHCO
44.9% more per $
CHCO
39.4%
-5.5%
TARS
More free cash flow
CHCO
CHCO
$115.5M more FCF
CHCO
$128.4M
$13.0M
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
5.3%
CHCO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCO
CHCO
TARS
TARS
Revenue
$80.2M
$151.7M
Net Profit
$31.6M
$-8.4M
Gross Margin
Operating Margin
49.3%
-5.3%
Net Margin
39.4%
-5.5%
Revenue YoY
11.8%
128.4%
Net Profit YoY
10.2%
63.8%
EPS (diluted)
$2.17
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCO
CHCO
TARS
TARS
Q4 25
$80.2M
$151.7M
Q3 25
$81.3M
$118.7M
Q2 25
$78.2M
$102.7M
Q1 25
$74.6M
$78.3M
Q4 24
$71.7M
$66.4M
Q3 24
$76.0M
$48.1M
Q2 24
$73.5M
$40.8M
Q1 24
$72.4M
$27.6M
Net Profit
CHCO
CHCO
TARS
TARS
Q4 25
$31.6M
$-8.4M
Q3 25
$35.2M
$-12.6M
Q2 25
$33.4M
$-20.3M
Q1 25
$30.3M
$-25.1M
Q4 24
$28.7M
$-23.1M
Q3 24
$29.8M
$-23.4M
Q2 24
$29.1M
$-33.3M
Q1 24
$29.5M
$-35.7M
Operating Margin
CHCO
CHCO
TARS
TARS
Q4 25
49.3%
-5.3%
Q3 25
54.0%
-12.2%
Q2 25
52.7%
-21.6%
Q1 25
49.5%
-33.5%
Q4 24
48.1%
-36.8%
Q3 24
48.9%
-52.3%
Q2 24
49.3%
-81.6%
Q1 24
50.6%
-136.5%
Net Margin
CHCO
CHCO
TARS
TARS
Q4 25
39.4%
-5.5%
Q3 25
43.3%
-10.6%
Q2 25
42.7%
-19.8%
Q1 25
40.7%
-32.1%
Q4 24
40.0%
-34.8%
Q3 24
39.2%
-48.7%
Q2 24
39.6%
-81.6%
Q1 24
40.8%
-129.4%
EPS (diluted)
CHCO
CHCO
TARS
TARS
Q4 25
$2.17
$-0.17
Q3 25
$2.41
$-0.30
Q2 25
$2.29
$-0.48
Q1 25
$2.06
$-0.64
Q4 24
$1.94
$-0.57
Q3 24
$2.02
$-0.61
Q2 24
$1.96
$-0.88
Q1 24
$1.97
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCO
CHCO
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$191.9M
$417.3M
Total DebtLower is stronger
$150.0M
$72.4M
Stockholders' EquityBook value
$809.7M
$343.4M
Total Assets
$6.7B
$562.2M
Debt / EquityLower = less leverage
0.19×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCO
CHCO
TARS
TARS
Q4 25
$191.9M
$417.3M
Q3 25
$225.6M
$401.8M
Q2 25
$172.1M
$381.1M
Q1 25
$384.7M
$407.9M
Q4 24
$225.4M
$291.4M
Q3 24
$293.9M
$317.0M
Q2 24
$218.0M
$323.6M
Q1 24
$318.7M
$298.5M
Total Debt
CHCO
CHCO
TARS
TARS
Q4 25
$150.0M
$72.4M
Q3 25
$150.0M
$72.3M
Q2 25
$150.0M
$72.1M
Q1 25
$150.0M
$72.0M
Q4 24
$150.0M
$71.8M
Q3 24
$150.0M
$71.7M
Q2 24
$150.0M
$71.6M
Q1 24
$150.0M
$29.9M
Stockholders' Equity
CHCO
CHCO
TARS
TARS
Q4 25
$809.7M
$343.4M
Q3 25
$798.9M
$335.1M
Q2 25
$764.2M
$332.6M
Q1 25
$756.3M
$342.5M
Q4 24
$730.7M
$224.5M
Q3 24
$741.3M
$237.5M
Q2 24
$686.7M
$252.2M
Q1 24
$682.2M
$275.2M
Total Assets
CHCO
CHCO
TARS
TARS
Q4 25
$6.7B
$562.2M
Q3 25
$6.7B
$534.6M
Q2 25
$6.6B
$495.0M
Q1 25
$6.6B
$500.8M
Q4 24
$6.5B
$377.0M
Q3 24
$6.4B
$376.3M
Q2 24
$6.3B
$376.8M
Q1 24
$6.3B
$349.3M
Debt / Equity
CHCO
CHCO
TARS
TARS
Q4 25
0.19×
0.21×
Q3 25
0.19×
0.22×
Q2 25
0.20×
0.22×
Q1 25
0.20×
0.21×
Q4 24
0.21×
0.32×
Q3 24
0.20×
0.30×
Q2 24
0.22×
0.28×
Q1 24
0.22×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCO
CHCO
TARS
TARS
Operating Cash FlowLast quarter
$131.4M
$19.3M
Free Cash FlowOCF − Capex
$128.4M
$13.0M
FCF MarginFCF / Revenue
160.2%
8.6%
Capex IntensityCapex / Revenue
3.6%
4.2%
Cash ConversionOCF / Net Profit
4.16×
TTM Free Cash FlowTrailing 4 quarters
$223.3M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCO
CHCO
TARS
TARS
Q4 25
$131.4M
$19.3M
Q3 25
$37.3M
$18.3M
Q2 25
$28.2M
$-29.4M
Q1 25
$31.5M
$-20.7M
Q4 24
$131.9M
$-22.2M
Q3 24
$37.6M
$-8.7M
Q2 24
$28.3M
$-14.4M
Q1 24
$32.2M
$-37.8M
Free Cash Flow
CHCO
CHCO
TARS
TARS
Q4 25
$128.4M
$13.0M
Q3 25
$35.8M
$16.3M
Q2 25
$27.8M
$-30.4M
Q1 25
$31.3M
$-21.2M
Q4 24
$129.2M
$-22.3M
Q3 24
$37.0M
$-8.9M
Q2 24
$27.8M
$-15.4M
Q1 24
$31.6M
$-38.0M
FCF Margin
CHCO
CHCO
TARS
TARS
Q4 25
160.2%
8.6%
Q3 25
44.0%
13.8%
Q2 25
35.6%
-29.6%
Q1 25
41.9%
-27.1%
Q4 24
180.2%
-33.5%
Q3 24
48.7%
-18.6%
Q2 24
37.8%
-37.8%
Q1 24
43.6%
-137.5%
Capex Intensity
CHCO
CHCO
TARS
TARS
Q4 25
3.6%
4.2%
Q3 25
1.9%
1.6%
Q2 25
0.5%
1.0%
Q1 25
0.3%
0.8%
Q4 24
3.8%
0.1%
Q3 24
0.9%
0.6%
Q2 24
0.7%
2.5%
Q1 24
0.8%
0.6%
Cash Conversion
CHCO
CHCO
TARS
TARS
Q4 25
4.16×
Q3 25
1.06×
Q2 25
0.85×
Q1 25
1.04×
Q4 24
4.60×
Q3 24
1.26×
Q2 24
0.97×
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons